SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob s who wrote (21)7/6/1997 11:20:00 AM
From: tonyt   of 123
 
Murphy was 'positive' on Anergen when it was at $6. He recomended buying it at $4 before the secondary as he thought the secondary by PaineWebber was going to increase exposure. Well, PW priced the secondary at $3 and hasn't said much since, nor has Murphy said much since (he's too busy touting INSV). Anyway, Anergen is still a good company and looks cheap at $3 (however, it fell pretty easily to $2 a couple of months ago for no good reason)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext